 |
 |

Ineffectiveness of Progesterone Suppository Treatment for Premenstrual Syndrome
Ellen Freeman, PhD;
Karl Rickels, MD;
Steven J. Sondheimer, MD;
Marcia Polansky, ScD
JAMA. 1990;264(3):349-353.
Abstract
 |  |
Progesterone is the most widely used treatment for premenstrual syndrome. To answer definitely the question of whether progesterone suppositories are effective for the treatment of premenstrual syndrome, a randomized, placebo-controlled, double-blind crossover study of 168 women, receiving progesterone in doses of 400 and 800 mg or placebo, was carried out. Premenstrual symptoms were not significantly improved by progesterone compared with placebo in any measure used in the study, including daily symptom reports maintained throughout treatment, clinician evaluation of improvement, and patient global reports of symptom severity, relief, and disruption of daily activity. No symptom cluster or individual symptom differed significantly between progesterone and placebo treatment. These treatment results were not significantly affected by fluctuations in response during the placebo washout period, pretreatment levels of depression or anxiety at either postmenstrual or premenstrual times, or any of 19 other background, medical history, or symptom variables examined individually as covariates with treatment.
(JAMA. 1990;264:349-353)
Author Affiliations
From the Department of Obstetrics/Gynecology (Drs Freeman, Rickels, and Sondheimer) and Psychiatry (Drs Freeman and Rickels), School of Medicine, University of Pennsylvania, Philadelphia; and Department of Biometrics and Computing, Hahnemann University, Philadelphia (Dr Polansky).
Footnotes
Reprint requests to Department of Obstetrics/Gynecology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (Dr Freeman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review
Wyatt et al.
BMJ 2001;323:776-776.
ABSTRACT
| FULL TEXT
Characteristics of Placebo Responses in Medical Treatment of Premenstrual Syndrome
Freeman and Rickels
Am. J. Psychiatry 1999;156:1403-1408.
ABSTRACT
| FULL TEXT
Gonadal Steroids in the Treatment of Mood Disorders
Epperson et al.
Psychosom. Med. 1999;61:676-697.
ABSTRACT
| FULL TEXT
Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual Syndrome
Schmidt et al.
NEJM 1998;338:209-216.
ABSTRACT
| FULL TEXT
Premenstrual Syndrome -- Pathophysiologic Considerations
Mortola
NEJM 1998;338:256-257.
FULL TEXT
Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
Yonkers et al.
JAMA 1997;278:983-988.
ABSTRACT
A Double-blind Trial of Oral Progesterone, Alprazolam, and Placebo in Treatment of Severe Premenstrual Syndrome
Freeman et al.
JAMA 1995;274:51-57.
ABSTRACT
Premenstrual Syndrome and Progesterone Suppositories
Mackenzie and Holton
JAMA 1991;265:26-26.
ABSTRACT
PROGESTERONE IS INEFFECTIVE FOR PREMENSTRUAL SYNDROME
JWatch General 1990;1990:2-2.
FULL TEXT
Efficacious Treatments of PMS: A Need for Further Research
Osofsky
JAMA 1990;264:387-387.
ABSTRACT
|